Agao, Samad B.

HRN: 18-19-29  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/02/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/02/2026
05/08/2026
IV
500MG
Q8H
INTESTINAL AMOEBIASIS
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: